Personalized ‘precision’ testing approach leads to efficient chest pain evaluations for heart disease risk

For people with stable chest pain, a personalized “precision” testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease when compared to usual care, according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2022.